Cellectis SA (CLLS)
1.86
-0.05
(-2.62%)
USD |
NASDAQ |
Nov 15, 16:00
1.86
0.00 (0.00%)
After-Hours: 16:27
Cellectis Free Cash Flow (Quarterly): -6.634M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -6.634M |
June 30, 2024 | 51.14M |
March 31, 2024 | -23.57M |
December 31, 2023 | 39.44M |
September 30, 2023 | -15.77M |
June 30, 2023 | -20.96M |
March 31, 2023 | -28.54M |
December 31, 2022 | -1.478M |
September 30, 2022 | -26.68M |
June 30, 2022 | -24.48M |
March 31, 2022 | -37.24M |
December 31, 2021 | -20.50M |
September 30, 2021 | -35.90M |
June 30, 2021 | -17.58M |
March 31, 2021 | -49.14M |
December 31, 2020 | -50.04M |
September 30, 2020 | -31.94M |
June 30, 2020 | -36.20M |
March 31, 2020 | -6.497M |
December 31, 2019 | -5.531M |
Date | Value |
---|---|
September 30, 2019 | -28.12M |
June 30, 2019 | -24.24M |
March 31, 2019 | -24.21M |
December 31, 2018 | -23.07M |
September 30, 2018 | -16.24M |
June 30, 2018 | -13.10M |
March 31, 2018 | -20.61M |
December 31, 2017 | -10.04M |
September 30, 2017 | -16.26M |
June 30, 2017 | -11.87M |
March 31, 2017 | -16.82M |
December 31, 2016 | 0.532M |
September 30, 2016 | -4.38M |
June 30, 2016 | -12.89M |
March 31, 2016 | -30.01M |
December 31, 2015 | 27.69M |
September 30, 2015 | -5.476M |
June 30, 2015 | -18.73M |
March 31, 2015 | -4.302M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-50.04M
Minimum
Dec 2020
51.14M
Maximum
Jun 2024
-17.40M
Average
-22.26M
Median
Free Cash Flow (Quarterly) Benchmarks
Genfit SA | -- |
Edap TMS SA | -6.693M |
Adaptimmune Therapeutics PLC | 46.64M |
NuCana PLC | -1.569M |
TC BioPharm (Holdings) PLC | -3.062M |